Rethinking Uncomplicated UTIs: A Comprehensive Review of Diagnosis, Management, and Novel and Emerging Treatment Options
1.00 AMA PRA Credits
Overview
Learning Objectives
CME/ Information
Faculty and Disclosures
Program Overview
The high prevalence and significant personal and healthcare impact and the advancements in UTI management highlight the importance of accurate diagnosis, streamlined treatment protocols, and optimizing patient care.
HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.
Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.
By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications.
HCPs must remain familiar with the classification of UTIs, the common signs and symptoms of uncomplicated UTIs, readily available diagnostic tools, and appropriate antibiotic selection based on local resistance patterns. Furthermore, staying updated on evolving antibiotic resistance trends and the potential need for alternative therapies is crucial.
Effective management also requires clear communication and collaboration within healthcare teams to ensure optimal patient outcomes. This includes providing standardized education and support for patients to understand their condition, treatment options, and preventative measures.
By focusing on these collective efforts, we can ensure the best possible care for patients with uncomplicated UTIs and minimize the risk of complications.
Target Audience
This educational initiative is designed for primary care physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals in primary care.
Supporter Acknowledgement
This educational activity is supported by an independent educational grant from GSK.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- APPLY evidence-based guidelines to accurately interpret signs, symptoms, and laboratory test results for diagnosing uUTIs.
- UTILIZE evidence-based guidelines in selecting antimicrobial therapy for uncomplicated UTIs, thereby minimizing unnecessary antibiotic use.
- REVIEW the key factors contributing to treatment failure in patients with uncomplicated urinary tract infections.
- EVALUATE the impact of uUTI and treatment failure on patient well-being.
- INTEGRATE patient education and shared decision-making into their management of uUTIs,.
Accredited Provider
This activity is jointly provided by Global Education Group and Iridium Continuing Education.


Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Matt T. Rosenberg, MD
Director, Mid Michigan Health Centers
Jackson, MI
Jackson, MI
disclosures

Copyright © 2024


Stay Informed
To receive updates as soon as the new dates are confirmed, please share your email.
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
We appreciate your ongoing interest and look forward to keeping you informed with the latest details!
Thank you!